Handbook of Systemic Drug Treatment in Dermatology
CRC Press (Verlag)
978-0-367-86081-3 (ISBN)
The Handbook of Systemic Drug Treatment in Dermatology helps prescribers and patients make rational decisions about drug treatment while considering known risks and potential unwanted effects. Written for dermatologists, family practitioners, pharmacists and specialist nurses, this completely revised and updated third edition of a bestseller provides an accessible and concise aid to prescribing and monitoring systemic dermatologic therapy. For each drug or drug class, the book lists its classification, mode of action, formulations, dosages, suggested regimens, contraindications, important drug interactions, adverse effects, patient information, and more. This third edition includes new classes of drugs as well as information on updated guidelines for prescribing and monitoring established drugs.
FROM REVIEWS OF PREVIOUS EDITIONS
"This updated edition includes new arrivals… Quite simply, it is indispensable! I have it with me in every clinic and often refer to it in discussions with pharmacists (who have been known to borrow my copy and forget to return it)." Dermatology in Practice
"... an outstanding resource that helps to alleviate worrying by providing precise guidelines and advice in managing our most infirm patients who require these medications." SkinMed
Edited by Sarah H. Wakelin, BSc, MB, BS, FRCP, Consultant Dermatologist and Honorary Seniro Lecturer, Imperial College Healthcare NHS Trust, London, UK Howard I. Maibach, MD, Professor of Dermatology, Department of Dermatology, University of California, San Francisco, USA Clive B. Archer, BSc, MBBS, MSc Med Ed, MD, PhD (Lond), FRCP, Consultant Dermatologist, St John’s Institute of Dermatology, Guy’s and St. Thomas’ Hospitals NHS Foundation Trust, Honorary Professor of Dermatology and Immunopharmacology (UCLan) and Honorary Senior Lecturer (KCL), London, UK
1. Acitretin. 2. Acne Antibiotics. 3. Alitretinoin 4. Antiandrogens. 5. Antibiotics Commonly Used for Skin Infections. 6. Antifungals. 7. Antimalarials. 8. Antivirals. 9. Apremilast. 10. Azathioprine. 11. Azole Antihelminths. 12. Bexarotene. 13. Ciclosporin. 14. Colchicine. 15. Corticosteroids. 16. Cyclophosphamide. 17. Dapsone. 18. Dimethyl Fumarate. 19. Interleukin 4/13 inhibitors. 20. Interleukin (IL)-12/23 and IL-23 Inhibitors. 21. Interleukin-17. antagonists. 22. Isotretinoin. 23. Ivermectin. 24. Intravenous Immunoglobulin. 25. Janus Kinase (JAK) Inhibitors. 26. Malignant Melanoma Drug Treatments. 27. Methotrexate. 28. Mycophenolate Mofetil. 29. Omalizumab. 30. Potassium Iodide. 31. Propranolol. 32. Psoralens. 33. Rituximab. 34. Sulfapyridine & Sulfamethoxy- pyridazine. 35. Thalidomide. 36. Tumour Necrosis Factor Antagonists. 37. Vismodegib. 38. Systemic Treatment in Children. 39. Kidney Disease. 40. Systemic Therapy & Liver Disease. 41. Systematic Therapy in Older People.
| Erscheinungsdatum | 27.01.2023 |
|---|---|
| Zusatzinfo | 29 Tables, black and white; 15 Line drawings, color; 3 Line drawings, black and white; 15 Illustrations, color; 3 Illustrations, black and white |
| Verlagsort | London |
| Sprache | englisch |
| Maße | 178 x 254 mm |
| Gewicht | 560 g |
| Themenwelt | Medizin / Pharmazie ► Allgemeines / Lexika |
| Medizin / Pharmazie ► Medizinische Fachgebiete ► Dermatologie | |
| Medizin / Pharmazie ► Medizinische Fachgebiete ► Pharmakologie / Pharmakotherapie | |
| Studium ► Querschnittsbereiche ► Prävention / Gesundheitsförderung | |
| ISBN-10 | 0-367-86081-3 / 0367860813 |
| ISBN-13 | 978-0-367-86081-3 / 9780367860813 |
| Zustand | Neuware |
| Informationen gemäß Produktsicherheitsverordnung (GPSR) | |
| Haben Sie eine Frage zum Produkt? |
aus dem Bereich
